Once again, the treatments are relatively the same as in females. There is FDA approval for male use of numerous bisphosphonates including Actonel and Fosamax, and the PTH agonist, Forteo. Estrogen and Evista are not used in men.

Low testosterone is an important cause of osteoporosis in this population. If this has been found to be the possible cause of disease, treatment with testosterone replacement can be considered.

As always, one has to evaluate all the possible risks and benefits of any therapies with their own physician or practitioner.

Learn more about male osteoporosis

Also read Health Journalist Craig Stoltz's analysis of a study about screening and treatment for male osteoporosis.